The coronavirus vaccine reduced the risk of major cardiovascular events linked to covid-19 by about 40 percent, according to a new study.
The findings suggest that such benefits observed in earlier studies have persisted for years. https://t.co/eFWhZ9XfpF
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19 https://t.co/PuBVxqzDnr
Ebola case count nears 600 as feds ask for travel restrictions ahead of World Cup.
In a new Lancet study, researchers estimate the outbreak could be more than double current numbers.
Read more: https://t.co/sw9iJcLrNh
📷: UN Photo/Martine Perret
The world is seeing far fewer deaths from infections that cause diarrhea.
Global deaths from infections that cause diarrhea and other intestinal illnesses fell from 3.7 million in 1990 to 1.3 million in 2023.
Read more: https://t.co/dNxBHM3wII
SARS-CoV-2 Primary Care Surveillance in England
Data from the RCGP Sentinel Surveillance system of around two thousand GP Practices.
In Week 22, ending 31 May 2026, the RCGP national average COVID-19 incidence rate for England decreased...
(RCGP data & chart)
When people think of adult social care and the pandemic, care homes often come to mind.
But the majority of care in the UK takes place in people's own homes - delivered by care workers and by millions of unpaid carers.
Ebola has a running head start. By the time the outbreak in DRC was detected, there were already many suspected cases and deaths. We’ve seen that if you reach an Ebola outbreak in days, you can stop it in weeks. Months of delay? It will take much, much longer. That’s why countries need to surge support to affected communities now. https://t.co/jkMXQwZ55w
Big progress vs cancer, folks.
The kind of event curves from randomized trials that we've not seen before for a couple of the most deadly cancers. Congrats to the oncology research community for getting these trial done. #ASCO26, @ASCO
Mortality and Morbidity Benefit After Influenza Vaccination in High Cardiovascular Risk Population: A Systematic Review and Meta-analysis - American Journal of Cardiology https://t.co/ipKy1NHsMB